⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3297030 | 1.00 | — | — | |
| SCHEMBL30005402 | 0.89 | PGD (0.34) | — | |
| SCHEMBL7038262 | 0.87 | — | — | |
| SCHEMBL21979551 | 0.87 | — | — | |
| SCHEMBL7040826 | 0.87 | — | — | |
| SCHEMBL3185415 | 0.87 | — | — | |
| SCHEMBL7137000 | 0.87 | — | — | |
| Trimethylammonium SCHEMBL9299889 | 0.84 | — | — | |
| SCHEMBL11751873 | 0.80 | — | — | |
| SCHEMBL28367449 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250066413-A1 | COMPOSITIONS FOR TREATMENT OF INFLAMMATION | METRO INTERNATIONAL BIOTECH, LLC | 2025-02-27 | — | — | US | disclosed |
| EP-4452279-A1 | COMPOSITIONS FOR TREATMENT OF INFLAMMATION | Metro International Biotech, LLC (US) | 2024-10-30 | — | — | EP | disclosed |
| US-11878994-B1 | Compositions for treatment of inflammation | METRO INTERNATIONAL BIOTECH, LLC (US) | 2024-01-23 | — | — | US | disclosed |
| WO-2023122190-A1 | COMPOSITIONS FOR TREATMENT OF INFLAMMATION | METRO INTERNATIONAL BIOTECH, LLC (US) | 2023-06-29 | — | — | WO | disclosed |